KIRK MEYERS: Open Payments
NPI 1740786243 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 28 payments from 10 companies in 2025. Trend: 2023 $848 · 2024 $692 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $128 |
| Kestra Medical Technology Services, Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $56 |
| PFIZER INC. | 3 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| BridgeBio Pharma, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: Ozempic, Assure WCD, ELIQUIS, LifeVest, LEQVIO, Attruby, REPATHA, Kerendia.
Industry payments across IN — which companies pay providers there.
